The sales of calcium supplement in Western Europe are set to advance at a CAGR of 7.2% from 2023 to 2033. The Western Europe calcium supplement industry is likely to attain a worth of US$ 1,826.8 million by 2033, up from US$ 914.9 million in 2023.
The future looks very promising for calcium supplement sales in Western Europe as people have become more health-conscious and take proactive measures to live a healthy lifestyle. For optimal bone health, calcium supplements are gaining popularity. Hence, there is going to be a rise in demand for calcium supplement in Western Europe due to a growing understanding of the scientific basis for the body's requirement for sufficient calcium and its benefits in maintaining a healthy heart, muscles, and nerves.
| Attributes | Details |
|---|---|
| Demand Analysis (2023) | US$ 914.9 million |
| Demand Forecast (2033) | US$ 1,826.8 million |
| CAGR Estimation (2023 to 2033) | 7.2% |
Insights into the Growth Drivers of Calcium Supplement Industry in Western Europe
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A thorough segmentation analysis of calcium supplements in Western Europe is given in this section. Manufacturers of calcium supplement in Western Europe closely monitor consumer trends, particularly the rising demand for soft gel pills. The men's segment is especially noteworthy within the end use category, indicating a significant market dynamic.
| Segment | Men |
|---|---|
| Industry Share in 2023 | 47.6% |
| Segment | Soft Gel Pills |
|---|---|
| Industry Share in 2023 | 54.3% |
Principal Consultant
The following table exhibits the expected market share for calcium supplements in Western Europe, emphasizing significant economies such as the United Kingdom, France, Italy, Germany, and Spain. It is clear from a thorough descriptive analysis that the United Kingdom has a bright future, especially because the nation is home to several significant producers of calcium supplements.
| Countries | Value CAGR from 2023 to 2033 |
|---|---|
| United Kingdom | 8.4% |
| Germany | 8.0% |
| France | 7.4% |
| Italy | 6.9% |
| Netherlands | 6.5% |
Intense competition among leading vendors in the Western European calcium supplement industry is a result of their efforts to satisfy the rising demand from consumers for bone health solutions. Prominent calcium supplement companies participate in strategic initiatives like partnerships, marketing campaigns, and product innovation to obtain a competitive edge.
The competitive landscape is dynamic due to the presence of established pharmaceutical and nutrition companies, and the evolving preferences of consumers toward preventive healthcare.
Key Breakthroughs in Calcium Supplement in Western Europe
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Valuation (2023) | US$ 914.9 million |
| Projected Valuation (2033) | US$ 1,826.8 million |
| Anticipated CAGR (2023 to 2033) | 7.2% |
| Historical Analysis of Calcium Supplement in Western Europe | 2018 to 2022 |
| Demand Forecast for Calcium Supplement in Western Europe | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Key Countries Analyzed while Studying Opportunities in Calcium Supplement in Western Europe | United Kingdom, Germany, France, Italy, Spain |
| Key Companies Profiled in the Industry Analysis of Calcium Supplement in Western Europe | Nature Made; By-health Co.,Ltd.; Harbin Pharmaceutical Group; Bayer AG; GlaxoSmithKline (GSK); GNC Holdings Inc.; Bio Island; Nature Bounty; High Change; Bluebonnet Nutrition; Pfizer (Caltrate); A&Z Pharmaceutical; Amway (Nutrilite); Shanxi Zhendong Pharmaceutical Co., Ltd.; BioCalth |
The sales of calcium supplement in Western Europe were valued at US$ 858.7 million in 2022.
The market value of calcium supplement in Western Europe is set to reach US$ 914.9 million in 2023.
The demand for calcium supplement in Western Europe is anticipated to rise at 7.2% CAGR from 2023 to 2033.
The Western Europe market size for calcium supplement is likely to surpass US$ 1,826.8 million by 2033.
The men segment is expected to dominate the calcium supplement industry with a share of 47.6% in 2023.
The HCAGR of sales of calcium supplement in Western Europe was 4.9% between 2018 and 2022.
1. Executive Summary 1.1. Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Gummy 5.3.2. Pill 5.3.3. Capsule 5.3.4. Liquid 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2023 to 2033 6.3.1. Calcium Carbonate 6.3.2. Calcium Gluconate 6.3.3. Calcium Citrate 6.3.4. Calcium Lactate 6.3.5. Calcium Phosphate 6.3.6. Calcium Orotate 6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Applications, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Applications, 2023 to 2033 7.3.1. Adult 7.3.2. Children 7.4. Y-o-Y Growth Trend Analysis By Applications, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Applications, 2023 to 2033 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Country, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Country, 2023 to 2033 8.3.1. UK 8.3.2. Germany 8.3.3. Italy 8.3.4. France 8.3.5. Spain 8.3.6. Rest of 8.4. Market Attractiveness Analysis By Country 9. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Region 9.2.1.1. England 9.2.1.2. Scotland 9.2.1.3. Wales 9.2.1.4. Northern Ireland 9.2.2. By Type 9.2.3. By Product 9.2.4. By Applications 9.3. Market Attractiveness Analysis 9.3.1. By Region 9.3.2. By Type 9.3.3. By Product 9.3.4. By Applications 9.4. Key Takeaways 10. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Region 10.2.1.1. North-east (Germany) 10.2.1.2. North-west (Germany) 10.2.1.3. Central (Germany) 10.2.1.4. South (Germany) 10.2.1.5. Other(Germany) 10.2.2. By Type 10.2.3. By Product 10.2.4. By Applications 10.3. Market Attractiveness Analysis 10.3.1. By Region 10.3.2. By Type 10.3.3. By Product 10.3.4. By Applications 10.4. Key Takeaways 11. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Region 11.2.1.1. North (Italy) 11.2.1.2. Central (Italy) 11.2.1.3. South (Italy) 11.2.1.4. Islands (Italy) 11.2.2. By Type 11.2.3. By Product 11.2.4. By Applications 11.3. Market Attractiveness Analysis 11.3.1. By Region 11.3.2. By Type 11.3.3. By Product 11.3.4. By Applications 11.4. Key Takeaways 12. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Region 12.2.1.1. Northern (France) 12.2.1.2. Central (France) 12.2.1.3. Southern (France) 12.2.1.4. Eastern (France) 12.2.2. By Type 12.2.3. By Product 12.2.4. By Applications 12.3. Market Attractiveness Analysis 12.3.1. By Region 12.3.2. By Type 12.3.3. By Product 12.3.4. By Applications 12.4. Key Takeaways 13. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Region 13.2.1.1. Basque Country 13.2.1.2. Andalusia 13.2.1.3. Extremadura 13.2.1.4. Catalonia 13.2.1.5. Valencia 13.2.1.6. Rest of Spain 13.2.2. By Type 13.2.3. By Product 13.2.4. By Applications 13.3. Market Attractiveness Analysis 13.3.1. By Region 13.3.2. By Type 13.3.3. By Product 13.3.4. By Applications 13.4. Key Takeaways 14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Type 14.2.2. By Product 14.2.3. By Applications 14.3. Market Attractiveness Analysis 14.3.1. By Type 14.3.2. By Product 14.3.3. By Applications 14.4. Key Takeaways 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Type 15.3.3. By Product 15.3.4. By Applications 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Tetra Chemicals Europe 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Pharma Manufacture 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Bayer AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. AandZ Pharmaceutical 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. GSK 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Bio Island 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Nature Made 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. By-health Co., Ltd. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Harbin Pharmaceutical Group 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Bayer AG 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports
Demand and Trend Analysis of Calcium Supplement in Western Europe
